SpinDiag GmbH. (7/20/17). “Press Release: SpinDiag Raises 1.6 Mio EUR Seed-Capital to Bring Its Revolutionary Point-of-Care Screening System for Antibiotic Resistance to Initial Testing in Hospitals”. Freiburg. – [LSE] Life-Sciences-Europe.com – The Europ

2023-05-25T10:16:26+02:00July 26th, 2017|In the press|

Life Sciences Business Intelligence for European countries Quelle: SpinDiag GmbH. (7/20/17). "Press Release: SpinDiag Raises 1.6 [...]